Correlation Between Kalvista Pharmaceuticals and Kura Oncology
Can any of the company-specific risk be diversified away by investing in both Kalvista Pharmaceuticals and Kura Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kalvista Pharmaceuticals and Kura Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kalvista Pharmaceuticals and Kura Oncology, you can compare the effects of market volatilities on Kalvista Pharmaceuticals and Kura Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kalvista Pharmaceuticals with a short position of Kura Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kalvista Pharmaceuticals and Kura Oncology.
Diversification Opportunities for Kalvista Pharmaceuticals and Kura Oncology
0.87 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Kalvista and Kura is 0.87. Overlapping area represents the amount of risk that can be diversified away by holding Kalvista Pharmaceuticals and Kura Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kura Oncology and Kalvista Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kalvista Pharmaceuticals are associated (or correlated) with Kura Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kura Oncology has no effect on the direction of Kalvista Pharmaceuticals i.e., Kalvista Pharmaceuticals and Kura Oncology go up and down completely randomly.
Pair Corralation between Kalvista Pharmaceuticals and Kura Oncology
Given the investment horizon of 90 days Kalvista Pharmaceuticals is expected to generate 0.98 times more return on investment than Kura Oncology. However, Kalvista Pharmaceuticals is 1.02 times less risky than Kura Oncology. It trades about -0.06 of its potential returns per unit of risk. Kura Oncology is currently generating about -0.17 per unit of risk. If you would invest 1,237 in Kalvista Pharmaceuticals on November 2, 2024 and sell it today you would lose (360.00) from holding Kalvista Pharmaceuticals or give up 29.1% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Kalvista Pharmaceuticals vs. Kura Oncology
Performance |
| Timeline |
| Kalvista Pharmaceuticals |
| Kura Oncology |
Kalvista Pharmaceuticals and Kura Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Kalvista Pharmaceuticals and Kura Oncology
The main advantage of trading using opposite Kalvista Pharmaceuticals and Kura Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kalvista Pharmaceuticals position performs unexpectedly, Kura Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kura Oncology will offset losses from the drop in Kura Oncology's long position.| Kalvista Pharmaceuticals vs. Surrozen | Kalvista Pharmaceuticals vs. Armata Pharmaceuticals | Kalvista Pharmaceuticals vs. Pasithea Therapeutics Corp | Kalvista Pharmaceuticals vs. Aditxt Inc |
| Kura Oncology vs. Protagonist Therapeutics | Kura Oncology vs. Merus BV | Kura Oncology vs. Replimune Group | Kura Oncology vs. Kalvista Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |